Atherothrombosis and oxidative stress: mechanisms and management in elderly
Significance: The incidence of cardiovascular events (CVEs) increases with age,
representing the main cause of death in an elderly population. Aging is associated with …
representing the main cause of death in an elderly population. Aging is associated with …
Antiplatelet agents in hemodialysis
M Migliori, V Cantaluppi, A Scatena, V Panichi - Journal of Nephrology, 2017 - Springer
Patients affected by cardiovascular disease (CVD) are treated with antiplatelet agents (AA)
and/or anticoagulant drugs, which are fundamental in the management of stroke, coronary …
and/or anticoagulant drugs, which are fundamental in the management of stroke, coronary …
Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long‐Term Outcome After Cardiac Surgery
N Kakouros, TJ Gluckman, JV Conte… - Journal of the …, 2017 - Am Heart Assoc
Background Systemic thromboxane generation, not suppressible by standard aspirin
therapy and likely arising from nonplatelet sources, increases the risk of atherothrombosis …
therapy and likely arising from nonplatelet sources, increases the risk of atherothrombosis …
[PDF][PDF] Koroner Arter Hastalığı Olan Hastalarda Aspirin Direncinin Serum Vitamin D Düzeyleri ile İlişkisi
S SÜRMEN, A ÖNCÜL - nek.istanbul.edu.tr
Amaç: Aterosklerotik kalp hastalığı olanlarda kardiyovasküler ters olaylarla D vitamini
eksikliği arasında güçlü bir ilişki olduğu yapılan birçok çalışma sayesinde bilinmektedir. Bu …
eksikliği arasında güçlü bir ilişki olduğu yapılan birçok çalışma sayesinde bilinmektedir. Bu …
Periferik arter hastalığında asetilsalisilik asit ve klopidogrel cevapsızlığı
E Coşkun, VY İmren - Batı Karadeniz Tıp Dergisi, 2017 - dergipark.org.tr
İki trombosit inhibitörü olan asetilsalisilik asit (ASA, aspirin) ve klopidogrel, farklı
mekanizmalarla etkilerini göstermektedir. Genellikle her iki ajanın periferik arter hastalığında …
mekanizmalarla etkilerini göstermektedir. Genellikle her iki ajanın periferik arter hastalığında …
Evaluation of Management of Patients with Cardiovascular Diseases on Acetylsalicylic Acid (Aspirin) as Antiplatelet
MK Soroor, MD Ali, AWH Mohammad… - Journal of …, 2017 - search.proquest.com
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels
and they include:* coronary heart disease* cerebrovascular disease* peripheral arterial …
and they include:* coronary heart disease* cerebrovascular disease* peripheral arterial …
[PDF][PDF] Let us know how access to this document benefits you.
N Kakouros, TJ Gluckman, JV Conte… - Hellenic Journal of …, 2017 - core.ac.uk
Background-—Systemic thromboxane generation, not suppressible by standard aspirin
therapy and likely arising from nonplatelet sources, increases the risk of atherothrombosis …
therapy and likely arising from nonplatelet sources, increases the risk of atherothrombosis …
[PDF][PDF] Variabilidad de la respuesta plaquetaria a la aspirina Variable platelet response to aspirin
S Fairley, PP McKeown - Medicina Residentes - siicsalud.com
Introduction: Despite the 25% reduction in major events with aspirin in high-risk patients
reported by the Antiplatelet Trialists' Collaboration, a proportion of patients develop recurrent …
reported by the Antiplatelet Trialists' Collaboration, a proportion of patients develop recurrent …
Platelet Dysfunction in Type-2 Diabetes Mellitus
GHR Rao - Mechanisms of Vascular Defects in Diabetes Mellitus, 2017 - Springer
Abstract According to the Diabetes Atlas of the World, published by the International
Diabetes Federation (IDF Diabetes Atlas, 7th edn, 2015), India has currently, over 70 million …
Diabetes Federation (IDF Diabetes Atlas, 7th edn, 2015), India has currently, over 70 million …